CIAM
ACAD icon

Caitong International Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Caitong International Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Buy
+595
New +$13.1K ﹤0.01% 1056
2025
Q2 		– Sell
-2,534
Closed -$42.1K – 1944
2025
Q1 		$42.1K Sell
2,534
-7,217
-74% -$131K 0.03% 551
2024
Q4 		$179K Buy
+9,751
New +$157K 0.18% 105

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Caitong International Asset Management's ACAD Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 595 shares worth $15.1K. The stake represents ﹤0.01% of the portfolio and ranks #1056 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in ACAD as recently as Q1 2025.

Caitong International Asset Management first reported a position in ACAD in Q4 2024 and has held it in 3 quarters since. The position peaked at $179K in Q4 2024. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Caitong International Asset Management held 595 shares of Acadia Pharmaceuticals worth $15.1K as of Q2 2026.
  • Acadia Pharmaceuticals was a new Caitong International Asset Management position in Q2 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1056 holding.
  • Caitong International Asset Management first reported a position in Acadia Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Caitong International Asset Management's Acadia Pharmaceuticals position peaked at $179K in Q4 2024.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.